"describe the pathway" is a grammatically correct phrase and can be used in written English.
Example: "Please take a moment to describe the pathway that led you to this decision."
As a likely explanation, in Fig. 4 is shown the proposed reaction mechanism to describe the pathway in which enzymatic epoxidation without lauric acid is accomplished.
In this review we describe the pathway, with a focus on the rationale for targeting the PI3K/AKT/mTOR pathway in patients with advanced urothelial carcinoma and considers the challenges that we face from the current clinical trials.
Despite a long history of research on the pathway, at this point in time we can only describe the pathway as a parts list and have almost no knowledge of the location of the complete pathway, how it is assembled, and whether there exists any trafficking of the enzymes or the carotenoids themselves.
We show that this screen is useful to identify regulators of plant cell death, and to further describe the pathway(s) engaging the resistance regulators EDS1/PAD4.
Here we go beyond the narrow documentation of final crystallization conditions that produced the refinement-data crystal, to describe the pathway to successful crystallization, data collection and phase determination of this difficult protein with the hope that our experiences will be instructive to others faced with challenging crystallization problems.
Here, we describe the pathway and provide the protocols and supporting tools necessary for wider use.
Given this limited evidence in the literature, we propose a novel framework to describe the pathways through which MSI emerge and their likely consequences for ecosystem services across multiple sites.
Following this conclusion, several mechanisms were proposed to describe the pathways traversed by a protein en route to the native state.
The described relatively short lengths are consistent with the interpretation that the fiber tracts observed in Figs 4 and 6 do not describe the pathways of single fibers, but rather the overall direction of fiber pathways in that area.
The results will provide valuable information about QOL and health outcomes of AAL solutions and seeks to describe the pathways influencing the investigated parameters by advanced ICT considering aspects of technology acceptance and usability concerns of the individuals.
Dr. Cotsarelis and Dr. Garza are co-inventors on a patent owned by the University of Pennsylvania describing the pathway by which the prostaglandin is inhibited at the receptor.
